Treatment & prevention of osteoporosis in postmenopausal women. Reduction in the risk of invasive breast cancer in postmenopausal women w/ osteoporosis &/or at high risk of invasive breast cancer.
Dosage/Direction for Use
1 tab daily.
May be taken with or without food.
Women of childbearing potential; active or history of venous thromboembolic events; severe hepatic impairment including cholestasis; severe renal impairment; unexplained uterine bleeding. Endometrial cancer.
History of stroke or other stroke risk factors eg, transient ischemic attack or atrial fibrillation. Co-administration w/ systemic estrogens is not recommended. In patient w/ history of oral oestrogen-induced hypertriglyceridaemia, monitor serum triglycerides. Complete breast cancer treatment before initiating raloxifene.